Research Article
miR-1291 Functions as a Potential Serum Biomarker for Bullous Pemphigoid
Table 2
Initial therapeutic regimens of the 45 BP patients.
| Therapeutic regimens | |
| Systemic prednisone (or equivalent) (mg/kg/day) | 39 | <0.5 | 6 | 0.5-0.75 | 19 | >0.75 | 14 | Oral nicotinamide and minocycline and topical halometasone | 6 |
|
|